Inhalable imatinib formulations, manufacture, and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11813263
APP PUB NO 20230086230A1
SERIAL NO

17887866

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AEROVATE THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dake, Ben Boston, US 15 12
Niven, Ralph Portola Valley, US 23 191

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 14, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00